Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
BTIG to hold a virtual conference » 08:32
08/10/20
08/10
08:32
08/10/20
08:32
MNKD

MannKind

$1.59 /

-0.065 (-3.94%)

Virtual Biotechnology…

Virtual Biotechnology Conference will be held on August 10-11.

ShowHide Related Items >><<
MNKD MannKind
$1.59 /

-0.065 (-3.94%)

MNKD MannKind
$1.59 /

-0.065 (-3.94%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.59 /

-0.065 (-3.94%)

Conference/Events
MannKind management to virtually meet with Cantor Fitzgerald » 04:55
08/06/20
08/06
04:55
08/06/20
04:55
MNKD

MannKind

$1.86 /

+0.205 (+12.42%)

Virtual Meeting to be…

Virtual Meeting to be held on August 6 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
MNKD MannKind
$1.86 /

+0.205 (+12.42%)

MNKD MannKind
$1.86 /

+0.205 (+12.42%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.86 /

+0.205 (+12.42%)

Earnings
MannKind reports Q2 EPS (5c), consensus (5c) » 16:06
08/05/20
08/05
16:06
08/05/20
16:06
MNKD

MannKind

$1.84 /

+0.185 (+11.21%)

Reports Q2 revenue…

Reports Q2 revenue $15.1M, consensus $14.62M. The company said, "A small 3% reduction in Afrezza TRx compared to the first quarter, when there was a bolus of prescriptions due to patient stockpiling, reflects the successful execution of our commercial plan in a new virtual environment. We faced many challenges during this quarter, but whether it was production personnel ensuring Afrezza supply through the end of the year, the research team producing clinical supplies for our collaboration partner, United Therapeutics, the field force executing new sales tactics or home office staff adapting to a totally virtual environment, our team exceeded all expectations."

ShowHide Related Items >><<
MNKD MannKind
$1.84 /

+0.185 (+11.21%)

MNKD MannKind
$1.84 /

+0.185 (+11.21%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.84 /

+0.185 (+11.21%)

Conference/Events
MannKind management to virtually meet with Cantor Fitzgerald » 13:37
08/05/20
08/05
13:37
08/05/20
13:37
MNKD

MannKind

$1.80 /

+0.15 (+9.09%)

Virtual Meeting to be…

Virtual Meeting to be held on August 6 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
MNKD MannKind
$1.80 /

+0.15 (+9.09%)

MNKD MannKind
$1.80 /

+0.15 (+9.09%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.80 /

+0.15 (+9.09%)

Hot Stocks
MannKind appoints Alejandro Galindo as CCO » 09:07
07/20/20
07/20
09:07
07/20/20
09:07
MNKD

MannKind

$1.72 /

+0.025 (+1.48%)

, MDT

Medtronic

$98.60 /

+2.86 (+2.99%)

MannKind Corporation…

MannKind Corporation (MNKD) announced that effective August 4, 2020, Alejandro Galindo, M.B.A, M.S., will be leading MannKind's commercial operations as CCO. Galindo will report directly to Michael Castagna, CEO and will serve on the company's executive leadership team. Galindo spent the past six years at Medtronic (MDT) as Vice President and President of the Advanced Insulin Management Business Unit.

ShowHide Related Items >><<
MNKD MannKind
$1.72 /

+0.025 (+1.48%)

MDT Medtronic
$98.60 /

+2.86 (+2.99%)

MNKD MannKind
$1.72 /

+0.025 (+1.48%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MDT Medtronic
$98.60 /

+2.86 (+2.99%)

07/17/20 B. Riley FBR
B. Riley FBR starts ClearPoint at Buy, sees potential takeover
07/16/20 Goldman Sachs
J&J delay to robotic surgery program a positive for Intuitive, says Goldman
07/09/20 Piper Sandler
Tandem, Medtronic deal meant to mitigate litigation risk, says Piper Sandler
06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
MNKD MannKind
$1.72 /

+0.025 (+1.48%)

MDT Medtronic
$98.60 /

+2.86 (+2.99%)

MDT Medtronic
$98.60 /

+2.86 (+2.99%)

MDT Medtronic
$98.60 /

+2.86 (+2.99%)

MDT Medtronic
$98.60 /

+2.86 (+2.99%)

Over a quarter ago
Conference/Events
Lytham Partners to hold a virtual conference » 04:55
06/25/20
06/25
04:55
06/25/20
04:55
MOGO

Mogo

$0.95 /

-0.0403 (-4.05%)

, SANW

S&W Seed

$2.21 /

-0.04 (-1.78%)

, MNKD

MannKind

$1.86 /

-0.265 (-12.47%)

, CDXC

ChromaDex

$4.46 /

-0.11 (-2.41%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, EAST

Eastside Distilling

$1.52 /

+0.03 (+2.01%)

, AZZ

AZZ Inc.

$32.75 /

-1.44 (-4.21%)

, ICCC

Immucell

$4.43 /

-0.105 (-2.32%)

, INFU

InfuSystem

$11.81 /

-0.5 (-4.06%)

, LIQT

LiqTech

$5.41 /

-0.17 (-3.05%)

, TNP

TEN, Ltd.

$2.02 /

-0.1 (-4.72%)

Investor Growth Virtual…

Investor Growth Virtual Conference will be held on June 24-25 at 9 am. Webcast Link

ShowHide Related Items >><<
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MOGO Mogo
$0.95 /

-0.0403 (-4.05%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

INFU InfuSystem
$11.81 /

-0.5 (-4.06%)

ICCC Immucell
$4.43 /

-0.105 (-2.32%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

MOGO Mogo
$0.95 /

-0.0403 (-4.05%)

06/04/20 B. Riley FBR
Mogo price target lowered to $3 from $4 at B. Riley FBR
03/30/20 B. Riley FBR
Mogo Finance price target lowered to $4 from $7 at B. Riley FBR
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

10/16/19
Fly Intel: Top five analyst initiations
10/16/19
Oppenheimer bullish on ChromaDex, initiates with an Outperform
10/15/19 Oppenheimer
ChromaDex initiated with an Outperform at Oppenheimer
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

ICCC Immucell
$4.43 /

-0.105 (-2.32%)

INFU InfuSystem
$11.81 /

-0.5 (-4.06%)

06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
TEN, Ltd. downgraded to Hold from Buy at Stifel
TNP TEN, Ltd.
$2.02 /

-0.1 (-4.72%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.21 /

-0.04 (-1.78%)

MNKD MannKind
$1.86 /

-0.265 (-12.47%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

EAST Eastside Distilling
$1.52 /

+0.03 (+2.01%)

CDXC ChromaDex
$4.46 /

-0.11 (-2.41%)

AZZ AZZ Inc.
$32.75 /

-1.44 (-4.21%)

LIQT LiqTech
$5.41 /

-0.17 (-3.05%)

Conference/Events
Lytham Partners to hold a virtual conference » 08:46
06/24/20
06/24
08:46
06/24/20
08:46
MOGO

Mogo

$0.99 /

+0.0046 (+0.46%)

, SANW

S&W Seed

$2.25 /

+ (+0.00%)

, MNKD

MannKind

$2.13 /

-0.08 (-3.63%)

, CDXC

ChromaDex

$4.57 /

-0.02 (-0.44%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

, EAST

Eastside Distilling

$1.49 /

+0.04 (+2.76%)

, AZZ

AZZ Inc.

$34.19 /

+0.52 (+1.54%)

, ICCC

Immucell

$4.53 /

+0.03 (+0.67%)

, INFU

InfuSystem

$12.31 /

+0.56 (+4.77%)

, LIQT

LiqTech

$5.58 /

-0.15 (-2.62%)

, TNP

TEN, Ltd.

$2.12 /

-0.095 (-4.29%)

Investor Growth Virtual…

Investor Growth Virtual Conference will be held on June 24-25 at 9 am. Webcast Link

ShowHide Related Items >><<
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.25 /

+ (+0.00%)

MOGO Mogo
$0.99 /

+0.0046 (+0.46%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

INFU InfuSystem
$12.31 /

+0.56 (+4.77%)

ICCC Immucell
$4.53 /

+0.03 (+0.67%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

MOGO Mogo
$0.99 /

+0.0046 (+0.46%)

06/04/20 B. Riley FBR
Mogo price target lowered to $3 from $4 at B. Riley FBR
03/30/20 B. Riley FBR
Mogo Finance price target lowered to $4 from $7 at B. Riley FBR
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
08/16/19 BMO Capital
Mogo Finance downgraded to Market Perform from Outperform at BMO Capital
SANW S&W Seed
$2.25 /

+ (+0.00%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

10/16/19
Fly Intel: Top five analyst initiations
10/16/19
Oppenheimer bullish on ChromaDex, initiates with an Outperform
10/15/19 Oppenheimer
ChromaDex initiated with an Outperform at Oppenheimer
SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

ICCC Immucell
$4.53 /

+0.03 (+0.67%)

INFU InfuSystem
$12.31 /

+0.56 (+4.77%)

06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

01/22/20 Lake Street
LiqTech analyst increases confidence in recovery, says Lake Street
12/17/19 Lake Street
LiqTech to recover from furnace throughput challenges, says Lake Street
11/14/19 Craig-Hallum
LiqTech post-earnings pullback a buying opportunity, says Craig-Hallum
09/06/19 Stephens
LiqTech can materially ramp revenue and profits in 2020, says Stephens
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

06/18/20
Fly Intel: Top five analyst downgrades
06/18/20 Stifel
TEN, Ltd. downgraded to Hold from Buy at Stifel
TNP TEN, Ltd.
$2.12 /

-0.095 (-4.29%)

SNWV Sanuwave Health
$0.00 /

+ (+0.00%)

SANW S&W Seed
$2.25 /

+ (+0.00%)

MNKD MannKind
$2.13 /

-0.08 (-3.63%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

EAST Eastside Distilling
$1.49 /

+0.04 (+2.76%)

CDXC ChromaDex
$4.57 /

-0.02 (-0.44%)

AZZ AZZ Inc.
$34.19 /

+0.52 (+1.54%)

LIQT LiqTech
$5.58 /

-0.15 (-2.62%)

Hot Stocks
MannKind presents original analyses of Afrezza clinical data » 09:14
06/15/20
06/15
09:14
06/15/20
09:14
MNKD

MannKind

$1.42 /

+ (+0.00%)

MannKind announced that…

MannKind announced that new data from clinical studies of Afrezza Inhalation Powder was presented at the American Diabetes Association's 80th Scientific Sessions, June 12-16, 2020. The data presented includes: A comprehensive post hoc analysis of four unique studies assessing the safe and effective dosing of Afrezza in patients with type 1 diabetes. An analysis demonstrating treatment with Afrezza is associated with weight loss in patients with type 2 diabetes, compared to weight gain with injected mealtime insulin. An evaluation of a comprehensive two year safety study showing that significant changes in FEV1 during treatment with Afrezza are both uncommon and generally transient in nature. Poster 1023: Dose Titration and Clinical Effects of Inhaled Technosphere Insulin Compared with Mealtime Subcutaneous Analog Insulin Therapy in Type 1 Diabetes: Ultra rapid-acting Afrezza can be safely and effectively dosed at 1.5 to 2.0 times that of injected mealtime insulin. This dosing ratio appears to be consistent across a range of A1C responses. Afrezza's ultra rapid-acting profile may supersede the perceived precision of injected mealtime insulin dosing and provides patients the ability to flexibly dose based on glycemic response. Poster 1024: Technosphere Insulin Added to Basal Insulin Is Associated with Less Weight Gain than Basal Insulin plus Insulin Aspart or Insulin Analog 70/30 Mixture in Type 2 DM: Patients with type 2 diabetes treated with Afrezza showed modest weight loss while those treated with insulin aspart or insulin aspart mix resulted in weight gain. The weight difference estimate between Afrezza and insulin aspart was 1.83 pounds. The weight difference estimate between Afrezza and biaspart insulin was 3.17 pounds. The effect on body weight was independent of the magnitude of improvement in glucose control. Oral Abstract 235: Incidence of Significant Changes in Pulmonary Function during A 2-year Study with Inhaled Technosphere Insulin: Prior clinical studies have shown a modest difference in mean change in FEV1 over two years when comparing treatment with Afrezza to other diabetes therapies. The majority of individuals treated with Afrezza had no significant change in FEV1 measured at any time. Overall, 98% of patients on Afrezza had either no significant change or were observed to have only a transient change in FEV1 over the two years of study.

ShowHide Related Items >><<
MNKD MannKind
$1.42 /

+ (+0.00%)

MNKD MannKind
$1.42 /

+ (+0.00%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.42 /

+ (+0.00%)

Conference/Events
MannKind management to virtually meet with Cantor Fitzgerald » 04:55
06/01/20
06/01
04:55
06/01/20
04:55
MNKD

MannKind

$1.51 /

+0.015 (+1.00%)

Virtual Meeting to be…

Virtual Meeting to be held on June 1 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
MNKD MannKind
$1.51 /

+0.015 (+1.00%)

MNKD MannKind
$1.51 /

+0.015 (+1.00%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.51 /

+0.015 (+1.00%)

Conference/Events
MannKind management to virtually meet with Cantor Fitzgerald » 11:58
05/28/20
05/28
11:58
05/28/20
11:58
MNKD

MannKind

$1.52 /

+0.005 (+0.33%)

Virtual Meeting to be…

Virtual Meeting to be held on June 1 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
MNKD MannKind
$1.52 /

+0.005 (+0.33%)

MNKD MannKind
$1.52 /

+0.005 (+0.33%)

12/24/19
Fly Intel: Top five analyst actions
12/24/19 Oppenheimer
MannKind initiated with an Outperform at Oppenheimer
10/25/19
Fly Intel: Top five analyst initiations
10/24/19 Cantor Fitzgerald
Cantor Fitzgerald starts MannKind at Overweight as Afrezza uptake gains traction
MNKD MannKind
$1.52 /

+0.005 (+0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.